Study identifies potential therapeutics target for metastatic melanoma
Source: King’s College London, November 2015
Researchers in the Randall Division of Cell & Molecular Biophysics have had the findings of their study into a potential therapeutics target for metastatic melanoma published in the journal Current Biology.
Entitled ‘TGFbeta -induced transcription sustains amoeboid melanoma migration and dissemination’, the study aims to understand if?the TGFbeta protein has some impact in melanoma progression, especially during metastatic dissemination – when cancer spreads from one part of the body to another, unconnected part.
Metatasis is the cause of death in 90% cancer patients. In order to help develop anti-metastasis therapies, a greater understanding of the signals that drive metastasis at the molecular level is needed….